Processing your payment...
Please do not close your browser.

Veterinary Therapeutics Market: - Global Growth, Trends and Forecast (2022 - 2029) By Type, By Distribution Channel, By Regions, By Key Players: Zoetis, Inc, Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim GmbH

24 Jun, 2022 | 117 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the Forecast Year, the Veterinary Therapeutics will register a CAGR of 5.2% in terms of revenue and the global market size will reach US$ 56.7 Billion by 2029.

Veterinary Therapeutics Market Overview

Increased geriatric population; the increased prevalence of eye diseases such as glaucoma, cataract, and macular degeneration; increased demand for ophthalmic drugs; and increased investment in R&D activities by various healthcare companies are the key factors driving the global ophthalmic drugs market forward. In addition, the market is expected to grow due to an increase in demand for ophthalmic pharmaceuticals, increased awareness about healthcare to reduce the risk of eye disorders, and government initiatives to develop and manufacture various combinations of ophthalmic drugs. However, the market growth is likely to be limited throughout the forecast period due to the long time it takes to manufacture and formulate an ophthalmic drug, as well as the adverse effects associated with ophthalmic drugs.

A major element propelling the global inhalation anaesthesia market ahead is the global occurrence of ailments such as respiratory diseases, gastrointestinal disorders, and cancer. Growing ongoing research and development in the healthcare industry will give profitable growth prospects for major companies in the worldwide market. Due to the availability of advanced healthcare facilities, healthcare treatment and service rates are considerably high in industrialised countries such as the United States and Canada.

 As a result of continual healthcare technology advancements, highly advanced technologies are used every day all around the world. Advances in science and technology have resulted in more effective disease prevention and recovery methods. Given that numerous technical advancements serve many medical professions, it's no wonder that such discoveries frequently produce ripples in the medical community.

What is our Veterinary Therapeutics Market Report Scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029 CAGR

 

CAGR of 5.2% during the review period (2022 to 2029).

 

By Type

  • Drugs
  • Anti-infective
  • Anti-inflammatory
  • Parasiticides
  • Others
  • Vaccines
  • Inactivated Vaccine
  • Live Attenuated Vaccine
  • Recombinant Vaccine
  • Others
  • Medicated Feed Additives
  • Antibiotics
  • Amino Acids
  • Others

 

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

 

 By Companies

 

 

 

  • Zoetis, Inc.
  • Merck Animal Health
  • Elanco Animal Health
  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Virbac
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Biovac
  • The Chanelle Group
  • Immu Cell Corporation.

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Base Year

 

 

2021

 

 

Historical Year

 

 

2016-2021

Forecast Year

 

2022-2029

Number of Pages

117

 

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Who are the Major Players in Veterinary Therapeutics Market?

The Veterinary Therapeutics Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise Distribution Channel products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. The main players in this market -  Zoetis, Inc, Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Biovac, The Chanelle Group, Immu Cell Corporation and Others.

Industry News

Ceva Santé Animale :- February 18, 2021, Paris: Philippe Mauguin, CEO of INRAE and Dr. Marc Prikazsky, Chairman & CEO of Ceva Santé Animale (Ceva), signed a first framework agreement aimed at consolidating their collaboration in animal health. This signature comes in the context of the Covid-19 pandemic and the outbreak of avian influenza in France. It affirms a shared objective of conducting joint "One Health” work, a global health concept at the crossroads of animal, human and environmental health and in particular, the prevention of infectious diseases of animal origin and the improvement of animal welfare.

What are the major Distribution Channels, Types for Veterinary Therapeutics?

By Type, it is segmented into

  • Drugs
    • Anti-infective
    • Anti-inflammatory
    • Parasiticides
    • Others
  • Vaccines
    • Inactivated Vaccine
    • Live Attenuated Vaccine
    • Recombinant Vaccine
    • Others
  • Medicated Feed Additives
    • Antibiotics
    • Amino Acids
    • Others

By Distribution Channels, it is segmented into

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

Veterinary Therapeutics Market Regional Analysis

This increase is mostly attributable to favorable government legislation, such as the EU Veterinary Medicines Regulation, as well as the growing popularity of pet insurance. Due to reasons such as the rising occurrence of zoonotic illnesses and advantageous reimbursement systems, North America was the second-largest regional market in 2021. Furthermore, market growth is likely to be aided by the increased acceptance of pet health insurance in the United States. Over the projected period, the Asia Pacific market is expected to develop at the fastest rate. Market expansion in this region has been aided by factors such as increased adoption of companion animals and rising animal health concerns. Furthermore, the market is likely to be driven by rising expenditure on animal health and veterinary services, as well as the growing cattle population.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
  • China North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
    •  
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
  1. INTRODUCTION
    • MARKET DEFINITION
    • MARKET DYNAMICS
    • MARKET SEGMENTATION
    • REPORT TIMELINES
    • KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    • DATA MINING
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
      • SUBJECT MATTER EXPERT ADVICE
    • QUALITY CHECK
    • FINAL REVIEW
      • DATA TRIANGULATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
      • RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    • INTRODUCTION
    • GLOBAL VETERINARY THERAPEUTICS TREATMENT BY TYPES
    • GLOBAL VETERINARY THERAPEUTICS BY APPLICATIONS
  4. MARKET DYNAMICS
    • DRIVERS
      • INCREASING DEMAND FOR VETERINARY THERAPEUTICS RESTRAINTS
      • STRINGENT ENVIRONMENTAL REGULATIONS
      • HIGH COST ON MATERIALS
    • OPPORTUNITIES
      • VETERINARY THERAPEUTICS GROWTH
      • APPLICATION OF VETERINARY THERAPEUTICS
      • IMPACT OF COVID 19
  5. GLOBAL VETERINARY THERAPEUTICS MARKET, BY TYPES
    • INTRODUCTION
  • DRUGS
    • ANTI-INFECTIVE
    • ANTI-INFLAMMATORY
    • PARASITICIDES
    • OTHERS
  • VACCINES
    • INACTIVATED VACCINE
    • LIVE ATTENUATED VACCINE
    • RECOMBINANT VACCINE
    • OTHERS
  • MEDICATED FEED ADDITIVES
    • ANTIBIOTICS
    • AMINO ACIDS
    • OTHERS
  1. GLOBAL VETERINARY THERAPEUTICS MARKET, BY APPLICATION
    • INTRODUCTION
    • VETERINARY HOSPITALS
    • VETERINARY CLINICS
    • PHARMACIES & DRUG STORES
    • OTHERS
  2. GLOBAL VETERINARY THERAPEUTICS MARKET, BY REGION
    • NORTH AMERICA
      • US
      • CANADA
      • MEXICO
    • EUROPE
      • GERMANY
      • FRANCE
      • UK
      • ITALY
      • RUSSIA
      • REST OF EUROPE
    • APAC
      • CHINA
      • SOUTH KOREA
      • JAPAN
      • INDIA
      • AUSTRALIA
      • ASEAN
      • REST OF APAC
    • MIDDLE EAST & AFRICA
      • SAUDI ARABIA
      • UAE
      • SOUTH AFRICA
      • TURKEY
      • REST OF MEA
    • SOUTH AMERICA
      • BRAZIL
      • REST OF MEA
      • ARGENTINA
      • REST OF SOUTH AMERICA
  3. COMPETITIVE LANDSCAPE
    • MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    • AND AGREEMENTS
      • KEY DEVELOPMENT
    • MARKET SHARE (%) **/RANKING ANALYSIS
    • STRATEGIES ADOPTED BY LEADING PLAYERS
  4. COMPANY PROFILES
    • BUSINESS OVERVIEW
    • COMPANY SNAPSHOT
    • PRODUCT BENCHMARKING
    • STRATEGIC INITIATIVES
  1. ZOETIS, INC.
  2. MERCK ANIMAL HEALTH
  3. ELANCO ANIMAL HEALTH
  4. BOEHRINGER INGELHEIM GMBH
  5. CEVA SANTÉ ANIMALE
  6. VIRBAC
  7. VETOQUINOL S.A.
  8. DECHRA PHARMACEUTICALS PLC
  9. BIOVAC
  10. THE CHANELLE GROUP
  11. IMMU CELL CORPORATION

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla